NO870437D0 - Cykloalkanol(1.2-6)indol-sulfonamider. - Google Patents
Cykloalkanol(1.2-6)indol-sulfonamider.Info
- Publication number
- NO870437D0 NO870437D0 NO870437A NO870437A NO870437D0 NO 870437 D0 NO870437 D0 NO 870437D0 NO 870437 A NO870437 A NO 870437A NO 870437 A NO870437 A NO 870437A NO 870437 D0 NO870437 D0 NO 870437D0
- Authority
- NO
- Norway
- Prior art keywords
- cycloalkanols
- indole sulfonamides
- sulfonamides
- indole
- Prior art date
Links
- RYMYQAMZUWJAEO-UHFFFAOYSA-N 1h-indole-2-sulfonamide Chemical class C1=CC=C2NC(S(=O)(=O)N)=CC2=C1 RYMYQAMZUWJAEO-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3605566 | 1986-02-21 | ||
DE19863631824 DE3631824A1 (de) | 1986-02-21 | 1986-09-19 | Cycloalkano(1.2-b)indol-sulfonamide |
Publications (4)
Publication Number | Publication Date |
---|---|
NO870437D0 true NO870437D0 (no) | 1987-02-04 |
NO870437L NO870437L (no) | 1987-08-24 |
NO171633B NO171633B (no) | 1993-01-04 |
NO171633C NO171633C (no) | 1993-04-14 |
Family
ID=25841196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO870437A NO171633C (no) | 1986-02-21 | 1987-02-04 | Analogifremgangsmaate for fremstilling av terapeutisk aktive cykloalkano(1.2-b)indol-sulfonamider |
Country Status (19)
Country | Link |
---|---|
US (3) | US4827032A (no) |
EP (1) | EP0242518B1 (no) |
JP (1) | JPH075552B2 (no) |
KR (2) | KR940007302B1 (no) |
AU (1) | AU595855B2 (no) |
CA (1) | CA1309414C (no) |
CS (1) | CS275837B6 (no) |
DE (2) | DE3631824A1 (no) |
DK (1) | DK167009B1 (no) |
ES (1) | ES2028801T3 (no) |
FI (1) | FI86544C (no) |
GR (1) | GR3001763T3 (no) |
HU (1) | HU198686B (no) |
IE (1) | IE59470B1 (no) |
IL (1) | IL81611A (no) |
NO (1) | NO171633C (no) |
NZ (1) | NZ219319A (no) |
PH (1) | PH24491A (no) |
PT (1) | PT84316B (no) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3826371A1 (de) * | 1988-08-03 | 1990-02-08 | Bayer Ag | Tetrahydro-1-benz-(c,d)-indolpropionsaeure-sulfonamide |
DE3829455A1 (de) * | 1988-08-31 | 1990-03-15 | Boehringer Mannheim Gmbh | Sulfonamidoalkyl-cyclohexan-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel |
US5070099A (en) * | 1988-10-31 | 1991-12-03 | E. R. Squibb & Sons, Inc. | Arylthioalkylphenyl carboxylic acids, derivatives thereof, compositions containing same method of use |
US4959383A (en) * | 1988-10-31 | 1990-09-25 | E. R. Squibb & Sons, Inc. | Phenylsulfone alkenoic acids, derivatives thereof, compositions containing same and method of use |
US5006542A (en) * | 1988-10-31 | 1991-04-09 | E. R. Squibb & Sons, Inc. | Arylthioalkylphenyl carboxylic acids, derivatives thereof, compositions containing same and method of use |
GB8924392D0 (en) * | 1989-10-30 | 1989-12-20 | Bayer Ag | Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides |
GB9008108D0 (en) * | 1990-04-10 | 1990-06-06 | Bayer Ag | Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles |
DE4027278A1 (de) * | 1990-08-29 | 1992-03-05 | Bayer Ag | Heterocyclisch substituierte indolsulfonamide |
US5827871A (en) * | 1991-06-26 | 1998-10-27 | Smithkline Beecham Plc | Medicaments 1,2,3,4-tetrahydrocarbazoles and 5-HT1 agonist use thereof |
DE4131346A1 (de) * | 1991-09-20 | 1993-03-25 | Bayer Ag | Indolsulfonamid substituierte dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
EP0603432B1 (en) * | 1992-12-18 | 1998-10-21 | Smithkline Beecham Plc | Tetrahydrocarbazole derivatives for the manufacture of a medicament for the treatment of a disease where a 5-HT1-like agonist is indicated |
DE19507751A1 (de) * | 1995-03-06 | 1996-09-12 | Bayer Ag | Verfahren zur Herstellung von substituierten 1,2,3,4-Tetrahydrocarbazolen |
US5708187A (en) * | 1996-06-27 | 1998-01-13 | Eli Lilly And Company | 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists |
DE19757983A1 (de) * | 1997-12-24 | 1999-07-01 | Bayer Yakuhin Ltd | Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban) |
WO2007019675A1 (en) * | 2005-08-12 | 2007-02-22 | Merck Frosst Canada Ltd. | Indole derivatives as crth2 receptor antagonists |
US7662831B2 (en) * | 2006-07-27 | 2010-02-16 | Wyeth Llc | Tetracyclic indoles as potassium channel modulators |
US7601856B2 (en) * | 2006-07-27 | 2009-10-13 | Wyeth | Benzofurans as potassium ion channel modulators |
MX2009001105A (es) | 2006-08-07 | 2009-02-10 | Actelion Pharmaceuticals Ltd | Derivados del acido (3-amino-1,2,3,4-tetrahidro-9h-carbazol-9-il)- acetico. |
GB0624087D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril combination salt |
GB0624090D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amine salts |
GB0624084D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amino acid salts |
EP2107907B1 (en) * | 2006-12-20 | 2012-02-01 | Cardoz AB | Combination of pemirolast and ramatroban for use in the treatment of inflammatory disorders |
WO2008087371A1 (en) * | 2007-01-16 | 2008-07-24 | Cardoz Ab | New combination for use in the treatment of inflammatory disorders |
WO2009007674A2 (en) * | 2007-07-11 | 2009-01-15 | Cardoz Ab | Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast |
US8501959B2 (en) * | 2008-06-24 | 2013-08-06 | Panmira Pharmaceuticals, Llc | Cycloalkane[B]indole antagonists of prostaglandin D2 receptors |
CA2728311A1 (en) | 2008-07-15 | 2010-01-21 | F. Hoffmann-La Roche Ag | Aminotetrahydroindazoloacetic acids |
JP2012508715A (ja) | 2008-11-17 | 2012-04-12 | エフ.ホフマン−ラ ロシュ アーゲー | ナフチル酢酸 |
NZ591914A (en) | 2008-11-17 | 2013-04-26 | Hoffmann La Roche | Naphthylacetic acids |
JP5373104B2 (ja) | 2008-11-17 | 2013-12-18 | エフ.ホフマン−ラ ロシュ アーゲー | Crth2アンタゴニスト又は部分アゴニストとして使用されるナフチル酢酸 |
MY183111A (en) | 2010-03-22 | 2021-02-15 | Idorsia Pharmaceuticals Ltd | 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators |
SG193902A1 (en) | 2011-04-14 | 2013-11-29 | Actelion Pharmaceuticals Ltd | 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators |
US8470884B2 (en) | 2011-11-09 | 2013-06-25 | Hoffmann-La Roche Inc. | Alkenyl naphthylacetic acids |
RS57867B1 (sr) | 2014-03-17 | 2018-12-31 | Idorsia Pharmaceuticals Ltd | Derivati azaindol sirćetne kiseline i njihova upotreba kao modulatora receptora prostaglandina d2 |
AU2015233046A1 (en) | 2014-03-18 | 2016-11-03 | Idorsia Pharmaceuticals Ltd | Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulators |
EP3256121B1 (en) | 2015-02-13 | 2024-08-07 | INSERM - Institut National de la Santé et de la Recherche Médicale | Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus |
CN108026093B (zh) | 2015-09-15 | 2021-11-16 | 爱杜西亚药品有限公司 | 结晶形式 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1415322A (fr) * | 1963-12-09 | 1965-10-22 | Eastman Kodak Co | Nouveaux composés de 3-sulfamidocyclobutanone et de 3-sulfamidocyclobutanol |
US3642816A (en) * | 1967-08-10 | 1972-02-15 | Sterling Drug Inc | 3-acetamido-1 2 3 4-tetrahydrocarbazole |
JPS4713658Y1 (no) * | 1969-12-18 | 1972-05-18 | ||
CH586678A5 (no) * | 1970-05-25 | 1977-04-15 | Hoffmann La Roche | |
DE2226702A1 (de) * | 1972-05-25 | 1973-12-13 | Schering Ag | Neue mittel zur behandlung des diabetes mellitus |
JPS5186117A (en) * | 1975-01-27 | 1976-07-28 | Tanabe Seiyaku Co | Johoseibiryushiseizainoseiho |
US4235901A (en) * | 1978-05-08 | 1980-11-25 | American Home Products Corporation | 1-Hydroxyalkanamine pyrano(3,4-b)indole compositions and use thereof |
-
1986
- 1986-09-19 DE DE19863631824 patent/DE3631824A1/de not_active Withdrawn
-
1987
- 1987-02-04 NO NO870437A patent/NO171633C/no unknown
- 1987-02-11 ES ES198787101901T patent/ES2028801T3/es not_active Expired - Lifetime
- 1987-02-11 DE DE8787101901T patent/DE3769191D1/de not_active Expired - Lifetime
- 1987-02-11 EP EP87101901A patent/EP0242518B1/de not_active Expired - Lifetime
- 1987-02-13 AU AU68808/87A patent/AU595855B2/en not_active Expired
- 1987-02-18 IL IL81611A patent/IL81611A/xx not_active IP Right Cessation
- 1987-02-18 NZ NZ219319A patent/NZ219319A/en unknown
- 1987-02-19 CS CS871093A patent/CS275837B6/cs unknown
- 1987-02-19 PH PH34883A patent/PH24491A/en unknown
- 1987-02-19 HU HU87650A patent/HU198686B/hu unknown
- 1987-02-19 FI FI870693A patent/FI86544C/fi not_active IP Right Cessation
- 1987-02-19 PT PT84316A patent/PT84316B/pt not_active IP Right Cessation
- 1987-02-19 CA CA000530077A patent/CA1309414C/en not_active Expired - Lifetime
- 1987-02-20 IE IE43987A patent/IE59470B1/en not_active IP Right Cessation
- 1987-02-20 KR KR1019870001410A patent/KR940007302B1/ko not_active IP Right Cessation
- 1987-02-20 DK DK087187A patent/DK167009B1/da not_active IP Right Cessation
- 1987-07-31 KR KR87008383A patent/KR960001914B1/ko not_active IP Right Cessation
-
1988
- 1988-06-29 US US07/212,840 patent/US4827032A/en not_active Expired - Lifetime
-
1989
- 1989-02-08 US US07/308,152 patent/US4904797A/en not_active Expired - Lifetime
- 1989-11-28 US US07/442,043 patent/US4965258A/en not_active Expired - Lifetime
-
1991
- 1991-04-11 GR GR91400361T patent/GR3001763T3/el unknown
-
1992
- 1992-02-27 JP JP4076232A patent/JPH075552B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO870437L (no) | Cykloalkanol(1.2-6)indol-sulfonamider. | |
LV5742B4 (lv) | 3,5-divalizvietoti pirokatehina atvasinajumi | |
DE3783669D1 (de) | Alpha-aryl-alpha-phenethyl-1h-1,2,4-triazol-1-propan-nitrile. | |
DE3762048D1 (de) | Antischaummittel. | |
DE3763411D1 (de) | 1,2,3,6-tetrahydro-5-nitro-pyrimidin-derivate. | |
FI875619A (fi) | 6-benzoxazinyl- och 6-benzotiazonyl-2,3,4,5-tetrahydropyridazin-3-oner. | |
DE3787548D1 (de) | Makrolid-verbindungen. | |
ATE74920T1 (de) | Substituierte indolochinoxaline. | |
FI874428A0 (fi) | Foerfarande foer framstaellning av vinylklorid medelst termisk spjaelkning av 1,2-dikloretan. | |
DE3786025D1 (de) | Makrolid-verbindungen. | |
DE3764006D1 (de) | Substituierte aminoxypropanoate. | |
DE3765646D1 (de) | 2,5,6,7-tetranor-4,8-inter-m-phenylen-pgi2-derivate. | |
FI881829A0 (fi) | 1,3-dioxaner. | |
FI880552A0 (fi) | Substituerade 2,6-substituerade pyridinfoereningar. | |
DE3766279D1 (de) | Substituierte aminoxypropionamide. | |
FI881899A0 (fi) | Nya 2 ,16 -diaminoandrostaner. | |
ES2015605B3 (es) | 3,4-dihidro-2h-piranos. | |
DE3788163D1 (de) | 1,3,5-Trithian-Derivate. | |
DK291687D0 (da) | 2-phenylacetyl-1,3,5-cyklohexantrioner | |
FI880081A (fi) | 2,1-bensotiazepin-2,2-dioxid-5 -karboxylsyraderivat. | |
DE3766275D1 (de) | Substituierte pyrimidoindole. | |
FI874140A (fi) | Elektronisk haollkrets foer via en abonnentledning matade tvaovaegstelefoner. | |
DE3761091D1 (de) | 2,6-dimethyl-p-benzochinontetraalkylketale. | |
FI914395A0 (fi) | Nya 5,6-substituerade 2,4-kinazo- lindiaminer. | |
ATE50254T1 (de) | 3,4-dihydro-4-oxo-2h-1-benzopyranyloxy-alkansaeu e-derivate. |